Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Fuller

Showing results (131-140 of 539) with videos related to

Pageof 54
Sort By:
Life Sciences|March 1, 1978
Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsR W Fuller, S K Hemrick
Advances in Experimental Medicine and Biology|January 1, 1981
Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptorsR W Fuller, N R Mason
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1978
Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to ratsR W Fuller, K W Perry
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1972
Substrate-selective and tissue-selective inhibition of monoamine oxidaseR W Fuller, B W Roush
Research Communications in Chemical Pathology and Pharmacology|September 1, 1973
Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in ratsR W Fuller, B B Molloy
Advances in Biochemical Psychopharmacology|January 1, 1974
Recent studies with 4-chloramphetamine and some analoguesR W Fuller, B B Molloy
Biochemical Pharmacology|August 1, 1974
5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferaseR W Fuller, B W Roush
Journal of Neural Transmission|January 1, 1979
Effect of mazindol on brain dopamine turnover in spiperone-treated ratsR W Fuller, H D Snoddy
The Journal of Pharmacy and Pharmacology|August 1, 1970
Inhibition by p-chloroamphetamine of the conversion of 5-hydroxytryptamine to 5-hydroxyindoleacetic acid in rat brainR W Fuller, C W Hines
Endocrinology|October 1, 1979
The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in ratsR W Fuller, H D Snoddy
Pageof 54

Showing results (131-140 of 539) with videos related to

Sort By:
Pageof 54
Life Sciences|March 1, 1978
Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated ratsR W Fuller, S K Hemrick
Advances in Experimental Medicine and Biology|January 1, 1981
Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptorsR W Fuller, N R Mason
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1978
Effect of uptake inhibitors on the depletion of brain norepinephrine and serotonin after alpha-methyl-m-tyrosine administration to ratsR W Fuller, K W Perry
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1972
Substrate-selective and tissue-selective inhibition of monoamine oxidaseR W Fuller, B W Roush
Research Communications in Chemical Pathology and Pharmacology|September 1, 1973
Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in ratsR W Fuller, B B Molloy
Advances in Biochemical Psychopharmacology|January 1, 1974
Recent studies with 4-chloramphetamine and some analoguesR W Fuller, B B Molloy
Biochemical Pharmacology|August 1, 1974
5,6-Dihydroxytryptamine is a substrate for catechol O-methyltransferaseR W Fuller, B W Roush
Journal of Neural Transmission|January 1, 1979
Effect of mazindol on brain dopamine turnover in spiperone-treated ratsR W Fuller, H D Snoddy
The Journal of Pharmacy and Pharmacology|August 1, 1970
Inhibition by p-chloroamphetamine of the conversion of 5-hydroxytryptamine to 5-hydroxyindoleacetic acid in rat brainR W Fuller, C W Hines
Endocrinology|October 1, 1979
The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in ratsR W Fuller, H D Snoddy
Pageof 54